BPC-157 is a fifteen-residue peptide, and confirming that a given batch matches that exact sequence at a documented purity level is what separates a usable research reagent from an unverified powder of unknown composition.
Why purity matters for a short peptide
Solid-phase synthesis of a fifteen-residue chain rarely produces a perfectly clean product on the first pass. Truncated sequences — chains that stopped one or more residues short of the full target — and other process-related byproducts form in small quantities during essentially every synthesis run. Without analytical verification, there's no way to know how much of a given vial is actually the intended peptide versus one of these near-miss variants, which is exactly the gap purity testing is designed to close.
HPLC as the primary purity method
High-performance liquid chromatography separates the target peptide from truncated and process-related impurities based on how each component interacts with a stationary phase as it moves through the column, then reports the result as a purity percentage. It's the workhorse method for peptide purity across the industry, and the underlying technique — what it measures and what it doesn't — is explained in understanding HPLC purity.
Mass spectrometry for identity confirmation
Purity and identity are two different questions, and HPLC alone only answers the first one. Mass spectrometry independently confirms that the measured molecular mass matches the mass expected for BPC-157's actual fifteen-residue structure, catching the rare case where an impurity happens to elute at nearly the same time as the target peptide without actually being the intended sequence. The chemistry behind that expected structure is covered in BPC-157 chemical structure and synthesis.
Batch-to-batch consistency
A single purity result only describes the batch it was measured on, which is why relying on an older Certificate of Analysis for a newly received vial doesn't actually confirm anything about that vial's contents. Reputable testing practices re-run both HPLC and mass spectrometry on each new production run rather than reusing prior results, since even small changes in synthesis conditions between batches can shift purity or introduce a different mix of byproducts.
Certificate of Analysis and independent verification
Results from both methods are compiled into a batch-specific Certificate of Analysis — the document a lab should be able to request and review before relying on a given lot, discussed in how to read a COA. Third-party verification, where an outside lab confirms the supplier's own results independently, adds a further layer of confidence beyond an in-house claim alone. BPC-157 vials sold with this documentation are available on the BPC-157 research vial page.
Research Use Only. Supplied strictly for laboratory research and development — not for human or veterinary use, consumption, or any therapeutic or diagnostic purpose. This article is research education, not usage guidance.